Literature DB >> 2901620

Virucidal treatment of clotting factor concentrates.

P M Mannucci1, M Colombo.   

Abstract

Mesh:

Substances:

Year:  1988        PMID: 2901620     DOI: 10.1016/s0140-6736(88)92426-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Viral contamination of monoclonal antibody preparations: potential problems and possible solutions.

Authors:  C Harbour; G Woodhouse
Journal:  Cytotechnology       Date:  1990-07       Impact factor: 2.058

2.  Viral safety and inhibitor development associated with monoclonal antibody-purified F VIII C.

Authors:  J M Lusher
Journal:  Ann Hematol       Date:  1991-09       Impact factor: 3.673

Review 3.  Hemophilia and von Willebrand's disease: 1. Diagnosis, comprehensive care and assessment. Association of Hemophilia Clinic Directors of Canada.

Authors: 
Journal:  CMAJ       Date:  1995-07-01       Impact factor: 8.262

Review 4.  Blood protein derivative viral safety: observations and analysis.

Authors:  B Horowitz
Journal:  Yale J Biol Med       Date:  1990 Sep-Oct
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.